Evidence map›Paper›PMID 39061302›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Chitosan-Integrated Curcumin-Graphene Oxide/Copper Oxide Hybrid Nanocomposites for Antibacterial and Cytotoxicity Applications.

Anandhavelu Sanmugam, Logesh Kumar Sellappan, Abbishek Sridharan, Swathy Manoharan, Ananda Babu Sairam, Abdulrahman I Almansour, Subha Veerasundaram, Hyun-Seok Kim, Dhanasekaran Vikraman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anandhavelu SanmugamDepartment of Applied Chemistry, Sri Venkateswara College of Engineering, Sriperumbudur 602117, India.
Logesh Kumar SellappanDepartment of Chemical Engineering, Indian Institute of Technology Hyderabad, Kandi 502285, India.ORCID 0000-0002-5794-3056
Abbishek SridharanMaterials Engineering, RWTH Aachen University, 52062 Aachen, Germany.ORCID 0000-0003-4722-2746
Swathy ManoharanDepartment of Biomedical Engineering, KPR Institute of Engineering and Technology, Coimbatore 641407, India.ORCID 0000-0001-8822-6343
Ananda Babu SairamDepartment of Applied Chemistry, Sri Venkateswara College of Engineering, Sriperumbudur 602117, India.
Abdulrahman I AlmansourDepartment of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Subha VeerasundaramDepartment of Chemistry, R.M.D. Engineering College, Tiruvallur 601206, India.
Hyun-Seok KimDivision of Electronics and Electrical Engineering, Dongguk University-Seoul, Seoul 04620, Republic of Korea.ORCID 0000-0003-1127-5766
Dhanasekaran VikramanDivision of Electronics and Electrical Engineering, Dongguk University-Seoul, Seoul 04620, Republic of Korea.ORCID 0000-0001-8991-3604

Funding

King Saud University RSP2024R231National Research Foundation of Korea 2019R1A2C2086747
6 · The paper itself

Abstract

This study deals with the facile synthesis of a single-pot chemical technique for chitosan-curcumin (CUR)-based hybrid nanocomposites with nanostructured graphene oxide (GO) and copper oxide (CuO) as the antibacterial and cytotoxic drugs. The physicochemical properties of synthesized hybrid nanocomposites such as CS-GO, CS-CuO, CS-CUR-GO, and CS-CUR-GO/CuO were confirmed with various advanced tools. Moreover, the in vitro drug release profile of the CS-CUR-GO/CuO nanocomposite exhibited sustained and controlled release during different time intervals. Also, the antibacterial activity of the CS-CUR-GO/CuO hybrid nanocomposite presented the maximum bactericidal effect against

Indexed as

antibacterialchitosanCuOcurcumincytotoxicitygraphene oxide

Identifiers

PMID39061302
PMCPMC11273410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.